| Product Code: ETC6361615 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Pneumococcal Vaccine Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Belgium Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Belgium Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Belgium Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Belgium Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Belgium Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Belgium Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Belgium Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Government initiatives promoting vaccination programs |
4.2.2 Increasing awareness about the importance of pneumococcal vaccines |
4.2.3 Rising prevalence of pneumococcal diseases in Belgium |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to vaccines in certain regions of Belgium |
4.3.3 Vaccine hesitancy among certain population groups |
5 Belgium Pneumococcal Vaccine Market Trends |
6 Belgium Pneumococcal Vaccine Market, By Types |
6.1 Belgium Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Belgium Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Belgium Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Belgium Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Belgium Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Belgium Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Belgium Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Belgium Pneumococcal Vaccine Market Export to Major Countries |
7.2 Belgium Pneumococcal Vaccine Market Imports from Major Countries |
8 Belgium Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates |
8.2 Number of educational campaigns conducted to raise awareness |
8.3 Rate of reported pneumococcal disease cases in Belgium |
8.4 Number of healthcare facilities offering pneumococcal vaccination services |
8.5 Percentage of high-risk populations vaccinated against pneumococcal diseases |
9 Belgium Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Belgium Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Belgium Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Belgium Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Belgium Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Belgium Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Belgium Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Belgium Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Belgium Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here